Publications by authors named "S Kauppinen"

Osteoarthritis (OA) is one of the most common degenerative joint diseases, with no effective therapeutic options available. In this study, we aimed to develop an interpenetrating, in-situ-forming hydrogel based on biocompatible and anti-fouling zwitterionic (ZI) polymers for early-stage OA treatment. We hypothesized that the anti-fouling properties of zwitterions could provide tissue protection, and the high charge density of these polymers would enhance tissue penetration and lubrication.

View Article and Find Full Text PDF

Objective: To characterize inflammatory and mechanical changes in the collagenase-induced OA (CIOA) model in rats.

Design: Skeletally mature, 6-month-old Wistar rats received unilateral intraarticular injections of saline, 500 U or 1000 U of collagenase on days 0 and 2 of the study. Joint tissues were harvested on either day 4 or 70 to evaluate the acute and long-term changes.

View Article and Find Full Text PDF
Article Synopsis
  • This study looks for a good way to find early signs of cartilage damage in osteoarthritis using rats as models.
  • Researchers developed a new scoring system called Cartilage Roughness Score (CRS) to measure damage and compared it with a traditional method.
  • The results showed that CRS works better than the old method and can help track how quickly cartilage gets worse over time.
View Article and Find Full Text PDF

Porous alkali-activated materials are synthetic aluminosilicates that should be often produced as granules for practical applications. In the present study, municipal solid waste incineration fly ash with ~1.2 wt% of metallic aluminium was used as a novel blowing agent for metakaolin (their ratio ranged from 0% to 100%) with an aqueous sodium silicate solution as the alkali-activator and granulation fluid in high-shear granulation.

View Article and Find Full Text PDF
Article Synopsis
  • * Current treatments mainly provide symptom relief, and effective therapies to modify the disease and protect neurons are limited.
  • * The nuclear factor-erythroid 2-related factor 2 (NRF2) plays a key role in defending cells from damage, making it a promising target for new treatments aimed at addressing neurodegeneration's root causes.
View Article and Find Full Text PDF